chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Migraine
Clinical narrative: I took my daughter, who was 13 at the time, to the pediatrician to get her "vaccines for middle school". I don't know the exact dates, but if I need to, I can get request her files. Once there, the doctor insisted that she get the new GARDASIL shots as well. She had me feeling that if I didn't, I wouldn't be a good mother, etc. Anyway, within a month of getting the shots, my daughter, began to have stomach issues that she never had before. It took me quite a while to connect it with the GARDASIL shots, but I can't think of anything else that it might be. We went to 3 different pediatricians, an allergist, 2 different gynecologists, and a gastroenterologist. All testing came up that she was ok, yet she had constant gastrointestinal issues (especially but not only whenever she ate), extreme fatigue, and migraines. She eats very healthy (has no choice since almost everything including healthy food makes her sick). After reading about the side effects that some girls are having after the shots, it appears that short of the paralysis (thank God), she has so many of what I am reading about. When confronting the doctors about whether it could be or not, they refuse to commit an answer to me. I begged them to stop pushing the shots on all of their patients fearing that someone else will respond the way my daughter has. She is 22 now and has been trying to live with her health issues, but she should not have to because people are making money off of families like mine. I refused to allow my son or younger daughter to get the shots after that and they are in good health. No one in my family has the same issues that my daughter does. I'm at my wits end and don't know what to do or how to help her. I feel as if everyone has given up on her. It's breaking my heart. I feel breaking my heart. I feel powerless. It tried to contact the maker of the drug, Merck, but I couldn't find a place to place my claim and since there are no doctors that will say anything negative about GARDASIL (I cant understand why), they made me feel like I was on the wrong track. But I don't feel as if I am so I'm starting here.
Age: 64.0
Sex: M
Vaccine: VARZOS
Symptoms: Blood test, Cardiac monitoring, Intensive care, Ventricular tachycardia
Clinical narrative: Implanted defibrillator detected ventricular tachycardia and shocked me 19 times. Admitted to the ICU.
Age: 61.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash, Rash erythematous
Clinical narrative: Patient developed a red rash over his trunk and extremities the evening after receiving the SHINGRIX vaccine. Rash was not painful or pruritic, just present. Patient reported the issue 19 days after it occurred and the rash was still present.
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Asthenia, Dizziness, Injection site pain, Injection site swelling
Clinical narrative: Pt stopped in office today reporting that the late morning after receiving the PNEUMOVAX 23 vaccine he developed dizziness (off & on), weakness (that was continuous), pain in his right bicep, and a swelling in his right anti cubital space. Sx's lasted "the rest of that day and the whole next day(yesterday)". Today Sx's have resolved, except for "slight trace of pain in the right bicep".  VAERS filled out an sent in.
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Gait disturbance, Guillain-Barre syndrome, Hypoaesthesia, Immunoglobulin therapy
Clinical narrative: This initial serious spontaneous case, received on 30-Nov-2017, reported by other health professional and concerns a 26-year-old, adult, female patient. The patient's current conditions included asthma (not used any inhaler for the past 3 years), the patient was allergic to prednisone and CIPRO. The patient's concomitant medication included BENADRYL. On 27-Sep-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 00644611A, expiry date: not reported). On same day, after administration of AFLURIA QUADRIVALENT, the patient felt like she had an itch which reached down to her leg and both the legs were numb. The patient was presented in the emergency room in which it was stated that, the symptoms were not related to the vaccine and thought it was due to a pinched nerve. The patient was discharged from the emergency room on the same day. It was reported that, the patient began to find difficulty in walking, more tingling and numbness in hands. The patient again went back to have an emergency visit on 29-Sep-2017 followed by hospitalization on the same day. The patient was treated with prednisone, but as the patient was allergic to prednisone, BENADRYL was administered along with prednisone. It was reported that, the patient's condition worsened, had difficulty in breathing and lost the use of fingers. At that point the physician decided it was GBS (Guillain Barre syndrome). The patient was then treated with IVIG (intravenous immunoglobulin) for one week and on oxygen for 2 days. It was reported that, the patient never required intubation. The patient was awake in ICU (intensive care unit) for one week and discharged from the hospital (07-Nov-2017 as reported). The patient received occupational therapy at hospital. As an outpatient, the patient was on physical therapy. The patient reported that she was back to handle activities of daily living but not 100 percent; she could walk short distances, but for further distances needed a walker. No numbness, coordination for weight lifting, gym work out had not returned to normal and she could not go to cross-fit training at present. The patient had not recovered from the events GBS, itch reached down to her leg, condition worsened, difficulty breathing, pinched nerve, tingling and numbness of hands and difficulty walking. The patient had recovered from the event numbness of extremities and patient's condition was improving as she could walk short distances. It was reported that, for further distances she needed a walker. The reporter assessed the case as serious (hospitalization, medically significant). Non-significant follow-up report received from the reporter on 05-Jan-2018: The patient's event onset date was confirmed as 27-Sep-2017. The patient's hospital admission date was confirmed as 29-Sep-2017, hence the hospitalization date was added (in the event tab).
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Intensive care, Loss of personal independence in daily activities, Musculoskeletal disorder, Nerve compression, Paraesthesia
Clinical narrative: This initial serious spontaneous case, received on 30-Nov-2017, reported by other health professional and concerns a 26-year-old, adult, female patient. The patient's current conditions included asthma (not used any inhaler for the past 3 years), the patient was allergic to prednisone and CIPRO. The patient's concomitant medication included BENADRYL. On 27-Sep-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 00644611A, expiry date: not reported). On same day, after administration of AFLURIA QUADRIVALENT, the patient felt like she had an itch which reached down to her leg and both the legs were numb. The patient was presented in the emergency room in which it was stated that, the symptoms were not related to the vaccine and thought it was due to a pinched nerve. The patient was discharged from the emergency room on the same day. It was reported that, the patient began to find difficulty in walking, more tingling and numbness in hands. The patient again went back to have an emergency visit on 29-Sep-2017 followed by hospitalization on the same day. The patient was treated with prednisone, but as the patient was allergic to prednisone, BENADRYL was administered along with prednisone. It was reported that, the patient's condition worsened, had difficulty in breathing and lost the use of fingers. At that point the physician decided it was GBS (Guillain Barre syndrome). The patient was then treated with IVIG (intravenous immunoglobulin) for one week and on oxygen for 2 days. It was reported that, the patient never required intubation. The patient was awake in ICU (intensive care unit) for one week and discharged from the hospital (07-Nov-2017 as reported). The patient received occupational therapy at hospital. As an outpatient, the patient was on physical therapy. The patient reported that she was back to handle activities of daily living but not 100 percent; she could walk short distances, but for further distances needed a walker. No numbness, coordination for weight lifting, gym work out had not returned to normal and she could not go to cross-fit training at present. The patient had not recovered from the events GBS, itch reached down to her leg, condition worsened, difficulty breathing, pinched nerve, tingling and numbness of hands and difficulty walking. The patient had recovered from the event numbness of extremities and patient's condition was improving as she could walk short distances. It was reported that, for further distances she needed a walker. The reporter assessed the case as serious (hospitalization, medically significant). Non-significant follow-up report received from the reporter on 05-Jan-2018: The patient's event onset date was confirmed as 27-Sep-2017. The patient's hospital admission date was confirmed as 29-Sep-2017, hence the hospitalization date was added (in the event tab).
Age: 26.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Walking aid user
Clinical narrative: This initial serious spontaneous case, received on 30-Nov-2017, reported by other health professional and concerns a 26-year-old, adult, female patient. The patient's current conditions included asthma (not used any inhaler for the past 3 years), the patient was allergic to prednisone and CIPRO. The patient's concomitant medication included BENADRYL. On 27-Sep-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: intramuscular, anatomical location: right deltoid, batch number: 00644611A, expiry date: not reported). On same day, after administration of AFLURIA QUADRIVALENT, the patient felt like she had an itch which reached down to her leg and both the legs were numb. The patient was presented in the emergency room in which it was stated that, the symptoms were not related to the vaccine and thought it was due to a pinched nerve. The patient was discharged from the emergency room on the same day. It was reported that, the patient began to find difficulty in walking, more tingling and numbness in hands. The patient again went back to have an emergency visit on 29-Sep-2017 followed by hospitalization on the same day. The patient was treated with prednisone, but as the patient was allergic to prednisone, BENADRYL was administered along with prednisone. It was reported that, the patient's condition worsened, had difficulty in breathing and lost the use of fingers. At that point the physician decided it was GBS (Guillain Barre syndrome). The patient was then treated with IVIG (intravenous immunoglobulin) for one week and on oxygen for 2 days. It was reported that, the patient never required intubation. The patient was awake in ICU (intensive care unit) for one week and discharged from the hospital (07-Nov-2017 as reported). The patient received occupational therapy at hospital. As an outpatient, the patient was on physical therapy. The patient reported that she was back to handle activities of daily living but not 100 percent; she could walk short distances, but for further distances needed a walker. No numbness, coordination for weight lifting, gym work out had not returned to normal and she could not go to cross-fit training at present. The patient had not recovered from the events GBS, itch reached down to her leg, condition worsened, difficulty breathing, pinched nerve, tingling and numbness of hands and difficulty walking. The patient had recovered from the event numbness of extremities and patient's condition was improving as she could walk short distances. It was reported that, for further distances she needed a walker. The reporter assessed the case as serious (hospitalization, medically significant). Non-significant follow-up report received from the reporter on 05-Jan-2018: The patient's event onset date was confirmed as 27-Sep-2017. The patient's hospital admission date was confirmed as 29-Sep-2017, hence the hospitalization date was added (in the event tab).
Age: 1.0
Sex: F
Vaccine: HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Injection site rash, Measles post vaccine, Pyrexia, Rash, Rhinorrhoea
Clinical narrative: Employee reported that pt started having the symptoms the next day. Running nose, rash on the (L) thigh and bilateral shoulders, fever. Employee states pt was seen in the clinic and was diagnosed with measles.
Age: 57.0
Sex: F
Vaccine: HEPA
Symptoms: Arthralgia, Dizziness, Fatigue, Headache, Inflammation
Clinical narrative: On 6/7/2018 in the morning client complained of severe headache, dizziness, and vomiting that morning only. Since then complaints of headache, nausea, joint pain, inflammation, and joint swelling, fatigue ongoing currently.
Age: 57.0
Sex: F
Vaccine: HEPA
Symptoms: Joint swelling, Nausea, Vomiting
Clinical narrative: On 6/7/2018 in the morning client complained of severe headache, dizziness, and vomiting that morning only. Since then complaints of headache, nausea, joint pain, inflammation, and joint swelling, fatigue ongoing currently.
Age: 4.0
Sex: F
Vaccine: HEP, HEPA, HEP, HEPA
Symptoms: Condition aggravated, Seizure
Clinical narrative: Mom reported child had a seizure at 11:00 AM on Saturday 06/16/2018. Taken to ER and was sent to Hospital in another city, was admitted and is being discharged today 06/18/2018.  Mom reported child was watching Cartoons at the onset of the seizure. Mom reported child has a history of seizures lasting 48 hrs as an infant when diagnosed with Spinal Meningitis but has not had seizure activity since. Mom is a Pharmacist is going to report a VAERS report as well.
Age: 4.0
Sex: F
Vaccine: HEP, HEPA, HEP, HEPA
Symptoms: Blood test normal, Computerised tomogram normal, Condition aggravated, Drooling, Electroencephalogram
Clinical narrative: Mom reported child had a seizure at 11:00 AM on Saturday 06/16/2018. Taken to ER and was sent to Hospital in another city, was admitted and is being discharged today 06/18/2018.  Mom reported child was watching Cartoons at the onset of the seizure. Mom reported child has a history of seizures lasting 48 hrs as an infant when diagnosed with Spinal Meningitis but has not had seizure activity since. Mom is a Pharmacist is going to report a VAERS report as well.
Age: 4.0
Sex: F
Vaccine: HEP, HEPA, HEP, HEPA
Symptoms: Full blood count normal, Lacrimation increased, Lethargy, Petit mal epilepsy, Staring
Clinical narrative: Mom reported child had a seizure at 11:00 AM on Saturday 06/16/2018. Taken to ER and was sent to Hospital in another city, was admitted and is being discharged today 06/18/2018.  Mom reported child was watching Cartoons at the onset of the seizure. Mom reported child has a history of seizures lasting 48 hrs as an infant when diagnosed with Spinal Meningitis but has not had seizure activity since. Mom is a Pharmacist is going to report a VAERS report as well.
Age: 4.0
Sex: F
Vaccine: HEP, HEPA, HEP, HEPA
Symptoms: Unresponsive to stimuli
Clinical narrative: Mom reported child had a seizure at 11:00 AM on Saturday 06/16/2018. Taken to ER and was sent to Hospital in another city, was admitted and is being discharged today 06/18/2018.  Mom reported child was watching Cartoons at the onset of the seizure. Mom reported child has a history of seizures lasting 48 hrs as an infant when diagnosed with Spinal Meningitis but has not had seizure activity since. Mom is a Pharmacist is going to report a VAERS report as well.
Age: 4.0
Sex: F
Vaccine: HEP, HEPA, HEP, HEPA
Symptoms: Condition aggravated, Seizure
Clinical narrative: Absence seizure. She became verbally unresponsive for many minutes. She was staring at the wall, eyes tearing up and had lots of drool coming from her mouth. We rushed her to the hospital where they did blood testing and gave her a CT scan, which was all normal. Once at the hospital, she slowly became more responsive, but was very lethargic for at least an hour after the event occurred. She was then sent to another hospital by ambulance. They did an EEG, the results of which we don't yet know. We have an appt. with a neurologist. The attending physician at second hospital agreed that it appears to have been a significant absence seizure.
Age: 4.0
Sex: F
Vaccine: HEP, HEPA, HEP, HEPA
Symptoms: Blood test normal, Computerised tomogram normal, Condition aggravated, Drooling, Electroencephalogram
Clinical narrative: Absence seizure. She became verbally unresponsive for many minutes. She was staring at the wall, eyes tearing up and had lots of drool coming from her mouth. We rushed her to the hospital where they did blood testing and gave her a CT scan, which was all normal. Once at the hospital, she slowly became more responsive, but was very lethargic for at least an hour after the event occurred. She was then sent to another hospital by ambulance. They did an EEG, the results of which we don't yet know. We have an appt. with a neurologist. The attending physician at second hospital agreed that it appears to have been a significant absence seizure.
Age: 4.0
Sex: F
Vaccine: HEP, HEPA, HEP, HEPA
Symptoms: Full blood count normal, Lacrimation increased, Lethargy, Petit mal epilepsy, Staring
Clinical narrative: Absence seizure. She became verbally unresponsive for many minutes. She was staring at the wall, eyes tearing up and had lots of drool coming from her mouth. We rushed her to the hospital where they did blood testing and gave her a CT scan, which was all normal. Once at the hospital, she slowly became more responsive, but was very lethargic for at least an hour after the event occurred. She was then sent to another hospital by ambulance. They did an EEG, the results of which we don't yet know. We have an appt. with a neurologist. The attending physician at second hospital agreed that it appears to have been a significant absence seizure.
Age: 4.0
Sex: F
Vaccine: HEP, HEPA, HEP, HEPA
Symptoms: Unresponsive to stimuli
Clinical narrative: Absence seizure. She became verbally unresponsive for many minutes. She was staring at the wall, eyes tearing up and had lots of drool coming from her mouth. We rushed her to the hospital where they did blood testing and gave her a CT scan, which was all normal. Once at the hospital, she slowly became more responsive, but was very lethargic for at least an hour after the event occurred. She was then sent to another hospital by ambulance. They did an EEG, the results of which we don't yet know. We have an appt. with a neurologist. The attending physician at second hospital agreed that it appears to have been a significant absence seizure.
Age: 36.0
Sex: F
Vaccine: FLU4
Symptoms: Bursitis, Immediate post-injection reaction, Injection site pain, Musculoskeletal pain, Neck pain
Clinical narrative: The flu shot was immediately very painful; I get the shot every year, and this was more painful than usual, by far. I also noticed how high it was on my arm---MUCH higher than I've ever seen before. For the first 3 days I had intense pain whenever I used the arm. After 3 days the intense pain decreased, but I still had very sharp pain when I lifted my arm or reached out in front of me or pushed out in any direction. This stayed constant for about a month and then the pain worsened in the areas all around my shoulder, particularly the back of my shoulder blade and my trapezoid. I was now in constant pain at a 3 or a 4 and still had sharp pain on lifting the arm overhead. At that time I started PT. I got an MRI (see below) which showed subacromial bursitis and fluid around some tendons. I received a cortisone shot to the subacromial bursa, which was ineffective. For another 2 months (we are at about month 3 now) the pain was constant and PT helped a little; anti-inflammatories helped a lot at high doses. At 4 months I flew out of state to see another doctor who used ultrasound imaging and he felt the location of the shot was a direct hit to the teres minor tendon insertion and he also saw a minor defect of the bone where the shot hit. He injected a lidocaine/saline solution to the exact spot under ultrasound guidance and I had temporary relief while the lidocaine was in effect (I could reach overhead, etc without pain). On my return my PT readjusted based on this information. At about 5 months some of the constant pain began to decrease, especially in the surrounding areas, but still had sharp pain on reaching overhead. At 6 months (now) this is the state---sometimes I have dull achey pain in the greater shoulder/shoulder blade/neck region at rest, but it's not constant; and I still have very sharp pain when I reach overhead. The original orthopedist now recommends surgery.
Age: 36.0
Sex: F
Vaccine: FLU4
Symptoms: Nuclear magnetic resonance imaging abnormal, Pain, Product administered at inappropriate site, Skeletal injury, Ultrasound scan abnormal
Clinical narrative: The flu shot was immediately very painful; I get the shot every year, and this was more painful than usual, by far. I also noticed how high it was on my arm---MUCH higher than I've ever seen before. For the first 3 days I had intense pain whenever I used the arm. After 3 days the intense pain decreased, but I still had very sharp pain when I lifted my arm or reached out in front of me or pushed out in any direction. This stayed constant for about a month and then the pain worsened in the areas all around my shoulder, particularly the back of my shoulder blade and my trapezoid. I was now in constant pain at a 3 or a 4 and still had sharp pain on lifting the arm overhead. At that time I started PT. I got an MRI (see below) which showed subacromial bursitis and fluid around some tendons. I received a cortisone shot to the subacromial bursa, which was ineffective. For another 2 months (we are at about month 3 now) the pain was constant and PT helped a little; anti-inflammatories helped a lot at high doses. At 4 months I flew out of state to see another doctor who used ultrasound imaging and he felt the location of the shot was a direct hit to the teres minor tendon insertion and he also saw a minor defect of the bone where the shot hit. He injected a lidocaine/saline solution to the exact spot under ultrasound guidance and I had temporary relief while the lidocaine was in effect (I could reach overhead, etc without pain). On my return my PT readjusted based on this information. At about 5 months some of the constant pain began to decrease, especially in the surrounding areas, but still had sharp pain on reaching overhead. At 6 months (now) this is the state---sometimes I have dull achey pain in the greater shoulder/shoulder blade/neck region at rest, but it's not constant; and I still have very sharp pain when I reach overhead. The original orthopedist now recommends surgery.
Age: 83.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Back pain, Dizziness, Dysgeusia, Erythema, Feeling abnormal
Clinical narrative: Patient received the Shingrix followed immediately by the Pneumovax23 and remained seated for a few minutes after the shot while waiting for her husband to receive the same injections. After about 5 minutes she looked red in the face stated that she felt hot with a weird taste in her mouth and that she felt really bad and nauseous and dizzy. She also complained of severe backpain. EMS was called in to assist and evaluate the patient.
Age: 83.0
Sex: F
Vaccine: PPV, VARZOS
Symptoms: Feeling hot, Nausea
Clinical narrative: Patient received the Shingrix followed immediately by the Pneumovax23 and remained seated for a few minutes after the shot while waiting for her husband to receive the same injections. After about 5 minutes she looked red in the face stated that she felt hot with a weird taste in her mouth and that she felt really bad and nauseous and dizzy. She also complained of severe backpain. EMS was called in to assist and evaluate the patient.
Age: 1.0
Sex: M
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Injection site swelling, Weight bearing difficulty, X-ray limb
Clinical narrative: Not bearing weight on right leg, slight swelling of right thigh for 7 days.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: Patient has complained of internal itching continuously since the vaccine. No rash or anything on the skin just extreme itching.
Age: 17.0
Sex: F
Vaccine: HPV9, MENB, MNQ
Symptoms: Anxiety, Consciousness fluctuating, Fatigue, Nausea, Vomiting
Clinical narrative: Per the client's stepmother: The client went to work following the injection and began to feel nauseous and tired. The client called her father to come pick her up, and threw up before he arrived. The client began to go in and out of consciousness in the car, so her father took her to the emergency room. There she was treated with IV fluids and diagnosed with an anxiety attack. Per the stepmother the client returned home that evening and is tired but otherwise feeling ok.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Headache, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Low grade fever for 48 hours. Headache for 2 hrs. Swelling and tenderness at site.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Headache, Injection site erythema, Injection site pain
Clinical narrative: Body aches, headache, fever, chills, fatigue. Tenderness, redness at injection site for 72 hours, redness spreading down arm to elbow.
Age: 59.0
Sex: M
Vaccine: VARZOS
Symptoms: Pain, Pyrexia
Clinical narrative: Body aches, headache, fever, chills, fatigue. Tenderness, redness at injection site for 72 hours, redness spreading down arm to elbow.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Rash
Clinical narrative: Patient developed a rash on the inside of her arm about 2 inches underneath the armpit.
Age: 68.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Cellulitis, Rash erythematous, Rash papular
Clinical narrative: Patient developed a rash on the inside of her arm about 2 inches underneath the armpit.
Age: 60.0
Sex: M
Vaccine: VARZOS
Symptoms: Mobility decreased
Clinical narrative: Pt is saying he can barely raise his arm.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Injection site erythema, Injection site inflammation, Injection site pain, Nausea, Pyrexia
Clinical narrative: Employee had fever of 99.8F and vomiting that started at approximately 10pm on 06/17/18. Injection site is inflamed and red. There is also pain on injection site. On 06/18/18 employee has fever of 99.8F and nausea. Employee took Paracetamol for fever and Piroxican for pain and swelling.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Swelling, Vomiting
Clinical narrative: Employee had fever of 99.8F and vomiting that started at approximately 10pm on 06/17/18. Injection site is inflamed and red. There is also pain on injection site. On 06/18/18 employee has fever of 99.8F and nausea. Employee took Paracetamol for fever and Piroxican for pain and swelling.
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash
Clinical narrative: Approximately 2-3 days after receiving the vaccine, patient broke out in a shingles rash on the forehead and continued to spread over a 2 week time period.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Arthralgia, Chills, Fatigue, Headache
Clinical narrative: Severe head and neck pain, muscle aches, joint pain, chills, fever, upset stomach, extreme tiredness, redness, pain, and swelling at injection site. It lasted 2 full days. I took ADVIL, and literally slept for 18 hours the day after the injection. I did not see a medical professional as my husband is a physician, and took care of me. I knew it was a reaction to the vaccine, and I figured it would eventually go away. It did on 06/17/2018.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Hypersomnia, Injection site erythema, Injection site pain, Injection site swelling, Myalgia
Clinical narrative: Severe head and neck pain, muscle aches, joint pain, chills, fever, upset stomach, extreme tiredness, redness, pain, and swelling at injection site. It lasted 2 full days. I took ADVIL, and literally slept for 18 hours the day after the injection. I did not see a medical professional as my husband is a physician, and took care of me. I knew it was a reaction to the vaccine, and I figured it would eventually go away. It did on 06/17/2018.
Age: 67.0
Sex: F
Vaccine: VARZOS
Symptoms: Neck pain, Pyrexia
Clinical narrative: Severe head and neck pain, muscle aches, joint pain, chills, fever, upset stomach, extreme tiredness, redness, pain, and swelling at injection site. It lasted 2 full days. I took ADVIL, and literally slept for 18 hours the day after the injection. I did not see a medical professional as my husband is a physician, and took care of me. I knew it was a reaction to the vaccine, and I figured it would eventually go away. It did on 06/17/2018.
Sex: F
Vaccine: PPV, TDAP
Symptoms: Exposure during pregnancy
Clinical narrative: Information has been received from the authors in a published literature article. This case concerns a 33 year old female patient pregnant with progressive hypogammaglobulinemia restricted to pregnancy starting, otitis media recurrent, sinusitis recurrent and pharyngitis streptococcal recurrent. The patient has a history of 5 previous pregnancies and 4 live birth(s). Protective titers Diphtheria, Haemophilus influenza, Mumps, Measles and Rubella. However, Tetanus titer was non protective and 1/14 antipneumococcal titers protective. On an unknown date, the patient was vaccinated with PNEUMOVAX23 for prophylaxis, and diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid (TDaP) (dose, frequency, route and lot# were unknown for both). The last menstrual period date (LMP) and end due date (EDD) were unknown. The pregnancy outcome and the fetal outcome were not provided. She was seen one and half years later, for prenatal counseling for her 4th pregnancy. Her immune evaluation included demonstrated protection to tetanus, Diphtheria and Streptococcal pneumoniae.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2015, the patient was inoculated with the ZOSTAVAX vaccine at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster. In 2016, he was treated at a hospital for the onset of a severe vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 08-AUG-2011, the patient was inoculated with ZOSTAVAX at a hospital as recommended for routine adult health maintenance and for the prevention of shingles (dose, lot, and route # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 27-AUG-2014, the patient was treated by a physician for the onset of a vesicular rash which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2007, the patient was inoculated with ZOSTAVAX at a hospital as recommended for routine adult health maintenance and for the prevention of shingles (dose, lot, and route # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. In 2011, the patient was treated at a physician's office for a persistent and severe vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Ophthalmic herpes zoster, Pain, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2007, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX "did function as intended," and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 01-JAN-2015, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as shingles. The patient was prescribed acyclovir for management of his painful symptoms. On or about 07-JAN-2015, the patient sought subsequent treatment by the physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster iridocyclitis and herpes zoster eyelid dermatitis along with blurred vision. The patient was prescribed prednisone, acyclovir and atropine for management of his painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, herpes zoster iridocyclitis and herpes zoster eyelid dermatitis were determined to be medically significant. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Vision blurred
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2007, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX "did function as intended," and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 01-JAN-2015, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as shingles. The patient was prescribed acyclovir for management of his painful symptoms. On or about 07-JAN-2015, the patient sought subsequent treatment by the physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster iridocyclitis and herpes zoster eyelid dermatitis along with blurred vision. The patient was prescribed prednisone, acyclovir and atropine for management of his painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, herpes zoster iridocyclitis and herpes zoster eyelid dermatitis were determined to be medically significant. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2012, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) by a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX "did function as intended," and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 03-SEP-2013, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as shingles. The patient was prescribed acyclovir for management of her painful symptoms. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a patient of unknown age and gender. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2012, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) by a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX "did function as intended," and the patient subsequently contracted a persistent strain condition of herpes zoster. On an unknown date in 2013, the patient was treated for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Herpes zoster, Varicella post vaccine
Clinical narrative: This spontaneous report was received from a consumer referring herself as currently non-pregnant adult female patient of unknown age. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported. On an unknown date, reported as when she was an infant, the patient was vaccinated with a shot of unspecified chicken pox vaccine (manufacturer unknown) (dose, units and frequency not reported) (lot# and expiration date unknown). On an unknown date, the patient developed chicken pox when she was in fourth grade. As an adult, she experienced shingles three times. Patient wanted to have children, so her physician recommended to get vaccine live VARIVAX, then wait for few months before planning for pregnancy. The patient was recovered from the events. The causal assessment was not provided.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Pain, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 24-APR-2012, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 18-SEP-2015, the patient was treated for a vesicular outbreak, which was diagnosed as herpes zoster. The patient was prescribed VALTREX, prednisone, and ibuprofen for management of her painful symptoms and chronic pain. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2009, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a hospital, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In March 2015, the patient was treated for a severe vesicular outbreak, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Rash vesicular
Clinical narrative: Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 01-MAR-2013, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. In May 2016, the patient was treated by a physician for a vesicular outbreak, which was diagnosed as herpes zoster or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Rash vesicular
Clinical narrative: This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 07-JUL-2015, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, lot, and route # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. The patient was treated at an urgent care for a blistering vesicular outbreak which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Sex: F
Vaccine: VARZOS
Symptoms: Blister, Herpes zoster, Rash vesicular
Clinical narrative: This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2013, the patient was inoculated with the ZOSTAVAX vaccine at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine "did" [considered an error] function as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. Later in 2013, she was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.